comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 08:52:25 - browse：6

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming success of its diabetes and obesity drug is unlike anything executives have seen before.

The company’s mid-year operating profit jumped from 37.5 billion Danish kroner in 2022 to 48.9 billion Danish kroner this year — “probably the strongest growth in the history of the company,” Chief Financial Officer Karsten Munk Knudsen said during an August earnings call. The 30% growth rate came from sales of semaglutide, which Novo Nordisk sells for diabetes under the name Ozempic and for obesity as Wegovy.

With its new blockbuster drug in hand, Novo Nordisk is valued higher than the entire economy of Denmark, where it’s based.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Readout LOUD podcast: possible new ALS drug, artificial wombs

WSS

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

How AI helped researchers track recovery from depression

Sutter Health’s antitrust win overturned by appeals court

How CO2 helps viruses stay alive longer in the air

Biotech lab space demand falls sharply

ASCO Takeaways: Winners, snoozers, and the art of cancer care

leisure time

comprehensive

entertainment

Continuity nursing helped my family in our darkest PICU moments

'Little Tech' descents on D.C., wanting a say in how AI is regulated

How to save PrEP access — and even expand it

Readout LOUD podcast: possible new ALS drug, artificial wombs

Novavax promises a turnaround & Lilly roils the obesity market

Intarcia’s device

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Virtual Event: Putting AI to the Test

Novavax promises a turnaround & Lilly roils the obesity market

Senate HELP committee spars over health care workforce policies

hotspot

Senators tussle over abortion against the backdrop of a presidential campaign

Elevance PBM president out as customers face prescription chaos

How Vertex's cystic fibrosis drug is changing patients' lives

Senate HELP committee spars over health care workforce policies

Senators: Long

FDA panel to weigh approval of NurOwn, controversial ALS drug

focus

hotspot

explore

focus